NCT03532906View on ClinicalTrials.gov

Feasibility Study on Pain Control After Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Postoperative Pain
Interventions
DRUG

TAP Block

Injection of Bupivacaine 0.5% 20 ml into the thickness of the right abdominal wall and of Bupivacaine 0.5% 10 ml into the surgical wounds.

DRUG

Control

Injection of Bupivacaine 0.5% 10 ml into the surgical wounds

Trial Locations (1)

EX25DW

Royal Devon and Exeter NHS Foundation Trust, Exeter

All Listed Sponsors
lead

Royal Devon and Exeter NHS Foundation Trust

OTHER

NCT03532906 - Feasibility Study on Pain Control After Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter